Published in NLN Publ on October 31, 1966
Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology (2001) 6.42
Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy. Neurology (2006) 3.68
Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy. Ann Neurol (2001) 3.46
Contrast extravasation on CT angiography predicts hematoma expansion in intracerebral hemorrhage. Neurology (2007) 3.38
Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy. Neurology (2010) 3.31
Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage. N Engl J Med (2000) 3.23
Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage. Neurology (2004) 2.85
The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation. J Exp Med (1995) 2.68
Warfarin-associated hemorrhage and cerebral amyloid angiopathy: a genetic and pathologic study. Neurology (2000) 2.59
White matter hyperintensity volume is increased in small vessel stroke subtypes. Neurology (2010) 2.49
Silent ischemic infarcts are associated with hemorrhage burden in cerebral amyloid angiopathy. Neurology (2009) 2.47
MR imaging detection of cerebral microbleeds: effect of susceptibility-weighted imaging, section thickness, and field strength. AJNR Am J Neuroradiol (2008) 2.40
Prior antiplatelet therapy and outcome following intracerebral hemorrhage: a systematic review. Neurology (2010) 2.39
Course of cerebral amyloid angiopathy-related inflammation. Neurology (2007) 2.33
Comparing proxy and patients' perceptions of patients' functional status: results from an outpatient geriatric clinic. J Am Geriatr Soc (1992) 2.16
White matter lesions, cognition, and recurrent hemorrhage in lobar intracerebral hemorrhage. Neurology (2004) 2.07
Progression of white matter lesions and hemorrhages in cerebral amyloid angiopathy. Neurology (2006) 2.06
Antiplatelet use after intracerebral hemorrhage. Neurology (2006) 1.88
Leukoaraiosis is associated with warfarin-related hemorrhage following ischemic stroke. Neurology (2002) 1.82
Pathogenic effects of D23N Iowa mutant amyloid beta -protein. J Biol Chem (2001) 1.74
Statin use and outcome after intracerebral hemorrhage: case-control study and meta-analysis. Neurology (2011) 1.50
Progression of cerebral amyloid angiopathy: accumulation of amyloid-beta40 in affected vessels. J Neuropathol Exp Neurol (1998) 1.47
Current pharmacotherapy for Alzheimer's disease. Annu Rev Med (2006) 1.45
Correlations between MRI white matter lesion location and executive function and episodic memory. Neurology (2011) 1.43
Impaired visual evoked flow velocity response in cerebral amyloid angiopathy. Neurology (2008) 1.42
Genetic variation at CR1 increases risk of cerebral amyloid angiopathy. Neurology (2012) 1.30
Structure of the rat platelet factor 4 gene: a marker for megakaryocyte differentiation. Mol Cell Biol (1987) 1.29
Association of homocysteine with plasma amyloid beta protein in aging and neurodegenerative disease. Neurology (2005) 1.26
Molecular mechanisms for memory: second-messenger induced modifications of protein kinases in nerve cells. Annu Rev Neurosci (1987) 1.24
Quantitation of apoE domains in Alzheimer disease brain suggests a role for apoE in Abeta aggregation. J Neuropathol Exp Neurol (2001) 1.22
Low cholesterol as a risk factor for primary intracerebral hemorrhage: A case-control study. Neuroepidemiology (1999) 1.22
Platelet factor-4 inhibits the mitogenic activity of VEGF121 and VEGF165 using several concurrent mechanisms. J Biol Chem (1995) 1.18
A molecular mechanism for long-term sensitization in Aplysia. Nature (1987) 1.16
Physicians' attitudes and practices regarding treatment of HIV-infected patients. South Med J (1992) 1.13
Warfarin-related intraventricular hemorrhage: imaging and outcome. Neurology (2011) 1.02
Genetic association of an alpha2-macroglobulin (Val1000lle) polymorphism and Alzheimer's disease. Hum Mol Genet (1998) 0.99
Cerebral microbleeds and cognitive functioning in the PROSPER study. Neurology (2011) 0.96
Structural studies on a family of cAMP-binding proteins in the nervous system of Aplysia. J Cell Biol (1986) 0.95
Elevated plasma thrombopoietic activity in patients with metastatic cancer-related thrombocytosis. Am J Med (1995) 0.95
Analysis of megakaryocyte ploidy in rat bone marrow cultures. Blood (1989) 0.94
Prevalence and effects of lobar microhemorrhages in early-stage dementia. Neurodegener Dis (2005) 0.94
Lipoxin generation by human megakaryocyte-induced 12-lipoxygenase. Biochim Biophys Acta (1992) 0.92
Alzheimer disease's double-edged vaccine. Nat Med (2003) 0.90
Plasma Abeta, homocysteine, and cognition: the Vitamin Intervention for Stroke Prevention (VISP) trial. Neurology (2009) 0.88
Abundant expression of ras proteins in Aplysia neurons. J Cell Biol (1986) 0.88
In vitro stimulation of megakaryocyte maturation by megakaryocyte stimulatory factor. J Biol Chem (1987) 0.81
Double sequential external shocks for refractory ventricular fibrillation. J Am Coll Cardiol (1994) 0.80
Feeding, oviposition and survival of Liriomyza trifolii (Diptera: Agromyzidae) on Bt and non-Bt cottons. Bull Entomol Res (2008) 0.80
Distribution of cAMP and cAMP-dependent protein kinases in Aplysia sensory neurons. J Neurosci (1987) 0.79
The nifedipine gastrointestinal therapeutic system in the treatment of hypertension. Am J Cardiol (1989) 0.77
Lack of independent associations of apolipoprotein E promoter and intron 1 polymorphisms with Alzheimer's disease. Neurosci Lett (1999) 0.76
Amyloid angiopathy. Neurology (1997) 0.75
Cerebral amyloid angiopathy and apolipoprotein E: bad news for the good allele? Ann Neurol (1997) 0.75
The effects of AbetaPP mutations and APOE polymorphisms on cerebral amyloid angiopathy. Amyloid (2001) 0.75
Study uncovers 'unnecessary' long-term stays in a short-term hospital. Hospitals (1967) 0.75
Inappropriate discharges of an implantable cardioverter defibrillator secondary to automatic adjustable gain of atrial tachycardia. Pacing Clin Electrophysiol (1997) 0.75
Nurses are key in HIP experiment to cut health care costs. Am J Nurs (1972) 0.75
Cyclic adenosine monophosphate-dependent mechanisms induce von Willebrand factor expression in the Dami megakaryoblastic cell line. Blood Coagul Fibrinolysis (1995) 0.75
The professional responsibility for the quality of health care. A discussion of methods. Panel discussion. Bull N Y Acad Med (1976) 0.75
Effects of planting dates on boll weevils (Coleoptera: Curculionidae) and cotton fruit in the subtropics. J Econ Entomol (2005) 0.75
Identification and characterization of a functional receptor for interferon-gamma on a megakaryocytic cell line. Blood (1991) 0.75
Deterrent effects of four neem-based formulations on gravid female boll weevil (Coleoptera: Curculionidae) feeding and oviposition on cotton squares. J Econ Entomol (2004) 0.75
Calcium-channel blockers in systemic hypertension. Curr Probl Cardiol (1987) 0.75
Observations on the participation of nurses and physicians in chronic care. Bull N Y Acad Med (1973) 0.75
Platelet membrane potentials and their significance in monitoring stimulus response coupling. Soc Gen Physiol Ser (1988) 0.75
Thrombin receptors on human platelets. Methods Enzymol (1992) 0.75